Injective (INJ) is currently priced at $6.01, reflecting a 2.33% increase over the past 24 hours. The daily trading range is relatively narrow at 0.34%, indicating stable price movements within the day, with a high of $6.09 and a low of $5.75.

The trading volume stands at approximately 68.8 million, translating to a volume-to-market cap ratio of 11.46%, which is indicative of active trading interest. Short-term moving averages suggest mixed signals: the 8 SMA is neutral at $6.01, while longer SMAs show upward trends, particularly the 55 SMA at $5.70 (+5.37%).

The 1-hour Relative Strength Index (RSI) is at 66, suggesting that INJ may be approaching overbought territory in the short term. Conversely, the 7-day RSI at 48 indicates a neutral market sentiment, while the price has declined by about 0.55% over the past week and over 10% in the past month.

The all-time high for INJ remains at $52.62, achieved in March 2024, which highlights significant price potential in the long term. However, the recent performance indicates a bearish trend over the past two weeks, with a 14-day price change of approximately -9.04%.

Given the current price stability, the increasing momentum in longer moving averages, and the mixed RSI signals, a cautious approach is warranted. Therefore, the recommendation for Injective (INJ) is to Hold, as it may present a recovery opportunity without immediate risk of significant downturn.